4/A: Fennec Pharmaceuticals Executive Christiana Cioffi Awarded 10,000 Restricted Share Units
SEC Form 4/A Filing
Christiana Cioffi, Chief Strategy Officer of Fennec Pharmaceuticals, was granted 10,000 restricted share units on March 28, 2025, according to a Form 4/A filing.
Summary
- Christiana Cioffi, Chief Strategy Officer of Fennec Pharmaceuticals, was awarded 10,000 restricted share units on March 28, 2025.
- These units were granted under the company's 2020 Equity Incentive Plan.
- The restricted share units will vest over time, starting with one-third of the shares being released on March 28, 2026.
- Following the Vesting Commencement Date, one twenty-fourth of the shares will be released monthly.
- Full vesting of the award will occur by February 29, 2028.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.
Positives
- The granting of restricted share units aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The vesting schedule suggests a commitment to the company's long-term performance.
Industry Context
Equity compensation is a common practice in the pharmaceutical industry to incentivize executives and align their interests with shareholders.
Comparison to Industry Standards
- Equity grants are a standard component of executive compensation packages in the pharmaceutical industry.
- Companies like Amgen, Gilead Sciences, and Biogen also utilize restricted stock units and stock options to incentivize their leadership teams.
- The vesting schedule is typical, with vesting periods ranging from three to five years.
Stakeholder Impact
- Shareholders may view the equity grant as a positive sign, aligning executive interests with company performance.
- Employees may see this as a sign of company stability and commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/28/2025 | Date of transaction: Christiana Cioffi was awarded restricted share units. |
| 03/28/2026 | Vesting Commencement Date: One-third of the shares subject to the award shall be released from restriction. |
| 02/29/2028 | 100% of the total number of shares subject to this award shall be released from restriction. |
| 04/03/2025 | Date of Form 4/A filing. |
Keywords
restricted share units, Fennec Pharmaceuticals, Christiana Cioffi, equity incentive plan, Form 4, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.